Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Horizon Therapeutics (NQ: HZNP )

109.17 -0.07 (-0.06%)
Streaming Delayed Price Updated: 11:39 AM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 139,307
Open 109.49
Bid (Size) 109.16 (4)
Ask (Size) 109.18 (1)
Prev. Close 109.24
Today's Range 109.03 - 109.49
52wk Range 57.84 - 117.49
Shares Outstanding 228,448,024
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
This Blue Chip Dividend Stock Should Return to Form When the Risk Premium Flips
T-bills may be the flavor of the month, but history has shown this top biotech stock is a far better long-term investment. 
Via The Motley Fool
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
From Horizon Therapeutics plc
Via Business Wire

Performance

YTD
-3.81%
-3.81%
1 Month
-0.29%
-0.29%
3 Month
-3.82%
-3.82%
6 Month
+74.14%
+74.14%
1 Year
+3.18%
+3.18%

More News

Read More
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $7,500 Today
Via Benzinga
New Analysis of MRI Findings Show UPLIZNA® (inebilizumab-cdon) Reduced the Formation of Asymptomatic Optic Nerve Lesions in People With Neuromyelitis Optica Spectrum Disorder (NMOSD)
From Horizon Therapeutics plc
Via Business Wire
Jeff Bezos, George Soros, Mark Cuban, and Ray Dalio All Have One Thing in Common: They're Making a Big Bet on This Industry
Via Benzinga
Horizon Therapeutics' Debt Overview
Via Benzinga
Here's How Much You Would Have Made Owning Horizon Therapeutics Stock In The Last 5 Years
Via Benzinga
Real-World Experience Shows TEPEZZA® (teprotumumab-trbw) Was Effective in Treating People With Dysthyroid Optic Neuropathy (DON)
From Horizon Therapeutics plc
Via Business Wire
7 Over-$100 Stocks That Are Worth Every Penny
Via InvestorPlace
Horizon Therapeutics plc - Rule 2.12 Announcement
From Horizon Therapeutics plc
Via Business Wire
Earnings Scheduled For March 1, 2023
Via Benzinga
Amgen Sinks On Mixed Earnings As 2023 Guidance Comes Up Short
Via Investor's Business Daily
Horizon Therapeutics plc Reports Fourth-Quarter and Full-Year 2022 Financial Results
From Horizon Therapeutics plc
Via Business Wire
Horizon Therapeutics plc Opens Applications for #RAREis Global Advocate Grant Program
From Horizon Therapeutics plc
Via Business Wire
Horizon Therapeutics plc Announces Voting Results from Special Shareholder Meetings
From Horizon Therapeutics plc
Via Business Wire
Jeff Bezos, George Soros, Mark Cuban, and Ray Dalio All Have One Thing in Common: They're Making a Big Bet on This Industry
Via Benzinga
New Data Suggest UPLIZNA® (inebilizumab-cdon) for the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) Did Not Increase the Risk of COVID-19 Infection or Reduce Antibody Levels From Childhood Vaccines
From Horizon Therapeutics plc
Via Business Wire
Nearly One-Third of Billionaire George Soros' Portfolio Is Invested in These 10 Stocks
Via The Motley Fool
Why Billionaires Paul Tudor Jones and George Soros Bought Up Horizon (HZNP) Stock
Via InvestorPlace
Billionaires Loaded Up on These 3 Stocks in the Fourth Quarter of 2022
Via The Motley Fool
Market Rally Powers Higher On Tame Fed, Meta Earnings; Apple, Google, Amazon In Focus: Weekly Review
Via Investor's Business Daily
Amgen Records Slight Fall In Quarterly Earnings; Lower COVID-19 Manufacturing Pacts Impact Bottomline
Via Benzinga
Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts
Via Benzinga
Horizon Therapeutics plc to Release Fourth-Quarter and Full-Year 2022 Financial Results on March 1, 2023
From Horizon Therapeutics plc
Via Business Wire
Rule 15 (c) Announcement – Horizon Therapeutics plc
From Horizon Therapeutics plc
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.